Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Infectious Disease

What is Directly Observed Therapy (DOT) for Tuberculosis?

At a Glance

Directly Observed Therapy (DOT) is the standard of care for tuberculosis where a healthcare worker watches you take your medication. It ensures a complete cure, prevents deadly drug-resistant TB, and provides ongoing support for managing side effects, with convenient video options now available.

In this answer

3 sections

01

Why is DOT Necessary?

02

How DOT Benefits You

03

Modern Alternatives to In-Person DOT

Directly Observed Therapy (DOT) is a globally recognized standard of care for tuberculosis (TB) where a healthcare worker or designated individual watches you take every dose of your TB medication [1][2]. Having someone watch you take your pills can feel frustrating, awkward, or intrusive, but it is not a punishment or a sign that your medical team doesn’t trust you. Instead, DOT is a vital safety net designed to help you successfully complete a very long, complex treatment while protecting your family and community from the spread of TB [3][4]. Depending on your treatment phase, DOT may happen daily or a few times a week [5].

Why is DOT Necessary?

Treating tuberculosis is different from treating a typical bacterial infection. Instead of a week or two of antibiotics, TB requires taking multiple medications for several months.

  • Ensuring a Complete Cure: TB bacteria die very slowly. Even after you feel completely better, surviving bacteria can hide in your body. DOT ensures you finish the entire course of medication, which significantly increases your chance of a full cure and improves your overall survival and quality of life [6][7][8].
  • Preventing Drug-Resistant TB: If you miss doses, stop taking the pills too early, or take them inconsistently, the surviving TB bacteria can mutate and “learn” how to fight off the medications. This creates Multi-Drug Resistant TB (MDR-TB), which is much deadlier, harder to treat, and requires medications with harsher side effects [9][10]. By taking every pill on schedule, you prevent the bacteria from mutating.
  • Protecting Your Loved Ones: Active TB can spread quickly through the air in households, schools, and communities [11]. By strictly adhering to your medication through DOT, you quickly become non-infectious, protecting the people around you.

How DOT Benefits You

While the public health reasons are important, DOT is primarily designed to support you as the patient:

  • Managing Side Effects: TB medications can cause difficult side effects like nausea, skin rash, joint pain, or even liver issues (such as yellowing of the eyes or skin). Seeing a healthcare worker regularly means you have an expert checking in on you. Speak up during your daily check-in if you notice these or other changes so your care team can catch side effects early and adjust your treatment [12][13].
  • Providing Support: Treatment can be exhausting and isolating. While having a stranger watch you swallow pills can feel clinical and awkward at first, try to view this worker as a resource and ally [14][15]. They can serve as a regular point of contact to help you navigate the everyday challenges of your treatment journey.

Modern Alternatives to In-Person DOT

Visiting a clinic every day or having a worker come to your home can be a heavy logistical burden involving travel costs, time off work, and childcare. Fortunately, modern TB care is becoming more flexible. Many clinics now offer Video-Observed Therapy (VOT) or digital alternatives [16][17]. With VOT, you use a smartphone or tablet to record yourself taking your medication or do a quick video call with your healthcare worker [18][19].

Studies show that video options are highly effective, cost less, save travel time, and are preferred by many patients while providing the same medical safety as in-person DOT [20][21]. Community-based DOT—where a trained community health worker supports you—is also an option in some areas [22][23].

Note: If you have an unavoidable emergency and cannot make your DOT appointment or take your scheduled VOT call, contact your healthcare team immediately to reschedule rather than simply skipping a dose.

Common questions in this guide

Why is Directly Observed Therapy (DOT) necessary for treating tuberculosis?
Treating tuberculosis requires taking multiple medications for several months. DOT ensures you finish the entire course safely, which increases your chance of a full cure and prevents the bacteria from mutating into a dangerous drug-resistant strain.
What is Video-Observed Therapy (VOT) for TB?
Video-Observed Therapy is a flexible alternative to in-person DOT visits that reduces travel time and costs. It allows you to use a smartphone or tablet to record yourself taking your medication or to complete a quick video call with your healthcare worker.
What happens if I experience side effects during my tuberculosis treatment?
TB medications can cause difficult side effects like nausea, skin rash, joint pain, or liver issues. You should report any new symptoms during your DOT sessions so your healthcare worker can catch issues early and adjust your treatment.
What should I do if I cannot make my DOT appointment?
If an unavoidable emergency arises, you should contact your healthcare team immediately to reschedule your visit or video call. It is critical that you do not simply skip a dose of your medication.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I eligible for Video-Observed Therapy (VOT) or a community-based DOT program to reduce the travel burden?
  2. 2.How can we schedule my in-person visits to minimize disruptions to my work or family schedule?
  3. 3.What is the exact process for reporting severe side effects, like nausea or yellowing skin, during my DOT sessions?
  4. 4.If I have an emergency and cannot make my DOT appointment, who should I contact to ensure I don't miss a dose?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does Ethambutol Cause Vision Problems? Risks & SymptomsDoes the BCG Vaccine Cause a False Positive TB Test?Does Tuberculosis Medication Affect Birth Control?How Long Are You Contagious After Starting TB Treatment?How Long After TB Exposure Do You Test Positive?How to Recover from TB Lung Scarring (PTLD)Is Tuberculosis Treatment Safe During Pregnancy?What Are the Signs of Liver Damage From TB Medication?What Are the Symptoms of TB Outside the Lungs?How is Multidrug-Resistant TB (MDR-TB) Treated?Will My Latent TB Become Active? Risk Factors ExplainedWhy You Need a Sputum Culture After a TB Blood Test

References

References (23)
  1. 1

    Telenursing Intervention for Pulmonary Tuberculosis Patients - A Scoping Review.

    Shalahuddin I, Pebrianti S, Eriyani T, Maulana I

    Journal of multidisciplinary healthcare 2024; (17()):57-70 doi:10.2147/JMDH.S440314.

    PMID: 38196938
  2. 2

    Tuberculosis and its Treatment: An Overview.

    Bansal R, Sharma D, Singh R

    Mini reviews in medicinal chemistry 2018; (18(1)):58-71 doi:10.2174/1389557516666160823160010.

    PMID: 27553018
  3. 3

    The Impact of Directly Observed Therapy on Successful Tuberculosis Treatment: A Statistical Analysis of National Notifications Data.

    Thompson RR, Ryuk DK, Pelissari DM, et al.

    Open forum infectious diseases 2026; (13(7)):ofag434 doi:10.1093/ofid/ofag434.

    PMID: 42500123
  4. 4

    Factors associated with unfavorable tuberculosis treatment outcomes in the population deprived of liberty.

    Ely KZ, Draschler ML, Prado TN, et al.

    IJTLD open 2025; (2(10)):570-576 doi:10.5588/ijtldopen.25.0210.

    PMID: 41089233
  5. 5

    Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.

    Yin J, Yuan J, Hu Y, Wei X

    PloS one 2016; (11(3)):e0150511 doi:10.1371/journal.pone.0150511.

    PMID: 26930287
  6. 6

    Survival and predictors of death in tuberculosis/HIV coinfection cases in Porto Alegre, Brazil: A historical cohort from 2009 to 2013.

    Brand ÉM, Rossetto M, Hentges B, et al.

    PLOS global public health 2021; (1(11)):e0000051 doi:10.1371/journal.pgph.0000051.

    PMID: 36962094
  7. 7

    Improvement in quality of life in pulmonary tuberculosis patients: a prospective study.

    Singh SK, Agrawal A, Tiwari KK

    Tropical doctor 2017; (47(2)):97-100 doi:10.1177/0049475516643256.

    PMID: 27178218
  8. 8

    Directly observed therapy for treating tuberculosis.

    Karumbi J, Garner P

    The Cochrane database of systematic reviews 2015; CD003343 doi:10.1002/14651858.CD003343.pub4.

    PMID: 26022367
  9. 9

    More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.

    Tesfay K, Tesfay S, Nigus E, et al.

    International journal of mycobacteriology 2016; (5(3)):324-327 doi:10.1016/j.ijmyco.2016.07.007.

    PMID: 27847018
  10. 10

    Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.

    Biset S, Teferi M, Alamirew H, et al.

    BMC infectious diseases 2024; (24(1)):238 doi:10.1186/s12879-024-09135-0.

    PMID: 38389060
  11. 11

    Cough and fever in an immigrant adolescent with abnormal chest X-ray.

    Giles N, Bhatia R

    Respiratory medicine case reports 2017; (20()):19-21 doi:10.1016/j.rmcr.2016.10.010.

    PMID: 27882294
  12. 12

    Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati.

    Li CT, Chu KH, Reiher B, et al.

    The Journal of international medical research 2017; (45(2)):610-620 doi:10.1177/0300060517694491.

    PMID: 28415942
  13. 13

    Engaging Adolescent Heart Transplant Recipients Through In-App Messaging During Mobile Health Intervention.

    Killian MO, Schelbe L, Lustria MLA, et al.

    Progress in transplantation (Aliso Viejo, Calif.) 2023; (33(3)):229-235 doi:10.1177/15269248231189862.

    PMID: 37491864
  14. 14

    Short-course therapy for tuberculosis: a discourse analysis.

    Sousa LO, Mitano F, Lima MC, et al.

    Revista brasileira de enfermagem 2016; (69(6)):1154-1163 doi:10.1590/0034-7167-2016-0330.

    PMID: 27925093
  15. 15

    Patients' perception towards directly observed treatment - A qualitative study from Kollam district, Kerala, southern India.

    Rakesh PS, Balakrishnan S, Krishnaveni V, et al.

    The Indian journal of tuberculosis 2017; (64(2)):93-98 doi:10.1016/j.ijtb.2016.11.007.

    PMID: 28410705
  16. 16

    Video-observed therapy (VOT) vs directly observed therapy (DOT) for tuberculosis treatment: A systematic review on adherence, cost of treatment observation, time spent observing treatment and patient satisfaction.

    Areas Lisboa Netto T, Diniz BD, Odutola P, et al.

    PLoS neglected tropical diseases 2024; (18(10)):e0012565 doi:10.1371/journal.pntd.0012565.

    PMID: 39405342
  17. 17

    Video-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis.

    Truong CB, Tanni KA, Qian J

    American journal of preventive medicine 2022; (62(3)):450-458 doi:10.1016/j.amepre.2021.10.013.

    PMID: 34916094
  18. 18

    Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini.

    Mukooza E, Schausberger B, Mmema N, et al.

    BMC infectious diseases 2024; (24(1)):829 doi:10.1186/s12879-024-09744-9.

    PMID: 39148081
  19. 19

    A Cost Analysis of Implementing Asynchronous Video Directly Observed Therapy for Monitoring Treatment in Patients with Tuberculosis Disease in Uganda.

    Tumuhumbise W, Kuteesa R, Nakkonde D, et al.

    Research square 2025; doi:10.21203/rs.3.rs-7911005/v1.

    PMID: 41333418
  20. 20

    Patient perceptions of video directly observed therapy for tuberculosis: a systematic review.

    Chen EC, Owaisi R, Goldschmidt L, et al.

    Journal of clinical tuberculosis and other mycobacterial diseases 2024; (35()):100406 doi:10.1016/j.jctube.2023.100406.

    PMID: 38380432
  21. 21

    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

    Story A, Aldridge RW, Smith CM, et al.

    Lancet (London, England) 2019; (393(10177)):1216-1224 doi:10.1016/S0140-6736(18)32993-3.

    PMID: 30799062
  22. 22

    Patient-perceived treatment burden of tuberculosis treatment.

    Ting NCH, El-Turk N, Chou MSH, Dobler CC

    PloS one 2020; (15(10)):e0241124 doi:10.1371/journal.pone.0241124.

    PMID: 33091084
  23. 23

    The role of digital health interventions for adults with tuberculosis: a network meta-analysis of randomized controlled trials.

    Duan Y, Liu J, Lin S, et al.

    Frontiers in medicine 2026; (13()):1840258 doi:10.3389/fmed.2026.1840258.

    PMID: 42344496

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or public health official regarding your tuberculosis treatment plan.

Get notified when new evidence is published on Tuberculosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.